COVID-19 Professional Solutions

企业介绍

Company Profile

百世诺(北京)医疗科技有限公司成立于2013年6月,是一家从事第三方医疗实验室服务和体外诊断产品研发、生产的国家级高新技术企业。始终专注于心脑血管精准医疗和公共卫生分子诊断领域。在公共卫生领域,百世诺拥有15年疾控产品研发和生产的专业经验,目前已拥有100多个病原检测产品。成功完成国内首批甲流、中东呼吸综合征检测试剂盒的研发和注册工作,已服务数千万人。

BestNovo (Beijing) Medical Technology Co., Ltd., founded in June 2013, is a National High-tech Enterprise, engaged in the third-party medical laboratory services and R&D and production of in vitro diagnostic producct.

It consistently concentrates on the fields of card-iocerebrovascular precision medicine and public health molecular diagnosis. In public health field, BestNovo has 15-year professional experience in the R&D and production of disease control pro-ducts, and possesses more than 100 products of pathogen detection so far. Successfully completed the R&D and registration of the first domestic de-tection kits of H1N1, MERS, etc, Bestnovo has served tens of millions of people.

百世诺下设百世诺(北京)医学实验室、江苏百世诺医疗科技有限公司等。

Members of BestNovo include BestNovo (Beijing) Medical Laboratory, BestNovo (Jiangsu) Medical Technology Co., Ltd., etc.


江苏百世诺医疗科技有限公司是国家药品监督管理局批准的专业医疗器械生产基地,拥有4000平方米G-MP标准厂房。拥有三条体外诊断试剂生产线,年生产能力2.5亿人次。成功开发新型冠状病毒(SARS-CoV-2)核酸检测试剂盒(荧光PCR法),COVID-19 IgM/IgG抗体诊断试剂盒(胶体金免疫层析法)。百世诺和中关村发展集团联合向湖北、浙江、重庆等疫区和北京COVID-19定点医院分批捐赠20000个COVID-19核酸诊断试剂盒。

BestNovo (Jiangsu) Medical Technology Co., Ltd. is a professional medical device production base approved by National Medical Products Administration with a 4000m2 GMP standard workshop. BestNovo has three production lines for in vitro diagnostic reagents with a total productivity of 250 million tests per year. During the COVID-19 pandemic, it successfully developed Novel Coron-avirus (SARS-CoV-2) Nucleic Acid Detection Kit (Real-time Fluorescent RT-PCR Assay) and COVID-19 IgM/IgG Antibody Diagnostic Kit (Colloidal Gold Immunochromatography Assay). To fight against the coronavirus, BestNovo and Zhongguancun Development Group (ZGC Group) jointly donated 20,000 COVID-19 Nucleic Acid Diagnostic Kits in batches to epidemic areas such as Hubei, Zhejiang, Chongqing and COVID-19 designated hospitals of Beijing.

新冠病毒核酸检测试剂盒(荧光PCR法)

Novel Coronavirus Nucleic Acid Detection Kit (Real-time Fluorescent RT-PCR)

本试剂盒用于体外定性检测新型冠状病毒感染疑似病例、疑似聚集性病例、其他需要进行新型冠状病毒感染诊断或鉴别诊断者的口咽拭子、鼻咽拭子和痰液样本中新型冠状病毒(SARS-CoV-2)ORF1ab基因、N基因。

The kit is intended for the qualitative detection of ORF1ab gene and N gene of Novel Coronavirus (SARS-CoV-2) from oropharyngeal swabs, nasopharyngeal swabs and sputum specimens to identify SARS-CoV-2 infection among suspected pneumonia cases, suspected clustered cases and other cases that require diagnosis or differential diagnosis of SARS-CoV-2 infection.

新冠病毒核酸检测试剂盒包装说明

Novel Coronavirus Nucleic Acid Detection Kit Package Introduction

新冠IgM/IgG抗体检测试剂盒

COVID-19 IgM/IgG Antibody Diagnostic Kit

新冠IgM/IgG抗体检测试剂盒包装说明

COVID-19 IgM/IgG Antibody Diagnostic Kit Package Introduction


采血套装

Blood Collection Package

产品资质

Product Certificate

1、百世诺新冠IgM/IgG抗体检测试剂盒国家注册检验报告

Test report of COVID-19 IgM/IgG Antibody Diagnostic Kit issued by Jiangsu Testing and Inspection Institute for Medical Device


2、百世诺新冠IgM/IgG 抗体检测试剂盒荷兰药监局注册信函

Letter of registration from the Netherlands Food and Drug Administration of COVID-19 IgM/IgG Antibody Diagnostic Kit


3、百世诺新冠IgM/IgG 抗体检测试剂盒欧盟CE认证

CE Notification Confirmation for COVID-19 IgM/IgG Antibody Diagnostic Kit


4、百世诺新冠核酸检测试剂盒国家注册检验报告

Test report of Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit issued by Jiangsu Testing and Inspection Institute for Medical Device


5、百世诺新冠核酸检测试剂盒荷兰药监局注册信函

Letter of registration from the Netherlands Food and Drug Administration of BestNovo Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit


6、百世诺新冠核酸检测试剂盒欧盟CE认证

CE Notification Confirmation for BestNovo Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit

Download »

Bestnovo-outline of data collection for overseas business

Interested in our Products?

please enter your E-mail or telephone number.

SEND